Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus-based biphasic immunosuppression vs Myfortic for early CNI withdrawal in renal transplantation
2006-004773-99Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sirolimus in Chronic Allograft Kidney Disease (CKaD) and kidney allograft rejection (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Surrogate markers of chronic allograft nephropathy and Comparative efficacy of the two immunosuppressive therapies. Started Jun 2007; status: completed.
02
Drugs
sirolimus
03
Conditions
Chronic Allograft Kidney Disease (CKaD)kidney allograft rejection
Beyond the preview
Go deeper on 2006-004773-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004773-99.